Ocular Herpes Simplex Virus: How are Latency, Reactivation, Recurrent Disease and Therapy Interrelated?Lena J Al-Dujaili, James M. Hill, Patrick P Clerkin et al.|Future Microbiology|2011Cited by 116
Rabbit and Mouse Models of HSV-1 Latency, Reactivation, and Recurrent Eye DiseasesJody M. Webre, Hilary W. Thompson, Christian Clément et al.|BioMed Research International|2012Cited by 91
A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular AngiogenesisPartha S. Bhattacharjee, James M. Hill, Richard A Graves et al.|PLoS ONE|2011Cited by 32
High-Glucose-Induced Endothelial Cell Injury Is Inhibited by a Peptide Derived from Human Apolipoprotein EPartha S. Bhattacharjee, James M. Hill, Tashfin S. Huq et al.|PLoS ONE|2012Cited by 27
Corneal neovascularization: a review of the molecular biology and current therapiesMichael L Rolfsen, James M. Hill, Nicholas E Frisard et al.|Expert Review of Ophthalmology|2013Cited by 18